Today we announced our initial post-approval access plans for our investigational HIV pre-exposure…
217 тыс. подписчиков
14 973 просмотра
11 комментариев
Комментарии из оригинального поста в X (Twitter)

@hapiku
"post-approval access plans" is a nice way of saying "we'll figure out pricing after the FDA does the hard part for us" - what's your actual strategy for making sure this isn't just another drug that's technically available but practically locked behind insurance hoops

@sophie_plum_k
so is this another $2k/month or are we actually making it accessible

@MarianaValcacio
聖地で撮った写真を見返すとまた涙が出る

@SSirood
B-17... natures prep.

@sofieruns41
what’s the uninsured copay strategy vs generic daily PrEP

@sophie1128_s
curious how you’re pricing it - tiered by risk or flat?

@lyric567_d
patient assistance program or just a copay card

@sophie_holl519
partnering with community clinics or big chains for distribution?

@sophiec26_l
curious how this compares to the daily pill for dosing

@s_jewe969
are you planning a 340B carve-out or a separate patient assistance program

@lunavic__f
hope this doesn't take another 20 years to actually become available

